Vol 7, No 6 (December 01, 2018): Chinese Clinical Oncology (Neoadjuvant Therapy for Ovarian Cancer)

Preface on Neoadjuvant Therapy for Ovarian Cancer1

Neoadjuvant therapy for ovarian cancer
Evgeny Imyanitov

Original Article

Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas
Thomas Ohnleiter, Delphine Antoni, François Lefebvre, Pierre Truntzer, Philippe Schultz, Mickael Burgy, Christian Borel, Georges Noël

Case Report

Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report
Bixia Tang, Xinan Sheng, Yan Kong, Zhihong Chi, Lu Si, Chuanliang Cui, Xieqiao Yan, Lili Mao, Bin Lian, Siming Li, Xuan Wang, Jie Dai, Xue Bai, Li Zhou, Jun Guo

Disclosure:

1. The series “Neoadjuvant Therapy for Ovarian Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Evgeny Imyanitov served as the unpaid Guest Editor for the series.

2. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.